A Study to Evaluate the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With Active, Difficult to Treat Rheumatoid Arthritis
Clinical trial NCT06754462 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06754462
- Sponsor
- Immunovant Sciences GmbH
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-10
- Primary completion
- 2027-09-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.